Barry Peters

Type 2 diabetes prevalence and its risk factors in HIV: A cross-sectional study

Alastair Duncan, Louise M. Goff, Barry Peters · PLoS ONE · 2018 · 127 citations · Full text

Medicine, Health Sciences, Diabetology +14

Randomized Trial to Evaluate Indinavir/Ritonavir versus Saquinavir/Ritonavir in Human Immunodeficiency Virus Type 1–Infected Patients: The MaxCmin1 Trial

Ulrik Bak Dragsted, Jan Gerstoft, Court Pedersen et al. · The Journal of Infectious Diseases · 2003 · 118 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity

Barry Peters, Walter Jaoko, Eftyhia Vardas et al. · Vaccine · 2006 · 109 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial

Richard B. Pollard, Jürgen K. Rockstroh, Giuseppe Pantaleo et al. · The Lancet Infectious Diseases · 2014 · 108 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS

Barry Peters, J. Winer, D. N. Landon et al. · QJM · 1993 · 100 citations

Medicine, Pathobiology, Pathology +14